SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 14, 2016	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-16-767512.pdf 0001193125-16-767512.rtf 0001193125-16-767512.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0000904454-16-001554.pdf 0000904454-16-001554.rtf 0000904454-16-001554.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149786.pdf 0001209191-16-149786.rtf 0001209191-16-149786.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149806.pdf 0001209191-16-149806.rtf 0001209191-16-149806.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149810.pdf 0001209191-16-149810.rtf 0001209191-16-149810.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149814.pdf 0001209191-16-149814.rtf 0001209191-16-149814.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149819.pdf 0001209191-16-149819.rtf 0001209191-16-149819.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149823.pdf 0001209191-16-149823.rtf 0001209191-16-149823.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149825.pdf 0001209191-16-149825.rtf 0001209191-16-149825.xls
Nov 14, 2016	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-16-149826.pdf 0001209191-16-149826.rtf 0001209191-16-149826.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE